David M. Cordas dos Santos

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

Kai Rejeski, Doris K. Hansen, Radhika Bansal et al. · Journal of Hematology & Oncology · 2023 · 117 citations · Full text

Medicine, Hematology, Oncology +17

Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy

Kai Rejeski, David M. Cordas dos Santos, Nathan H. Parker et al. · Cancer Immunology Research · 2023 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies

David M. Cordas dos Santos, Kai Rejeski, Michael Winkelmann et al. · Haematologica · 2022 · 46 citations · Full text

Life Sciences, Immunology, Oncology +16

Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL

Kai Rejeski, Viktoria Blumenberg, Gloria Iacoboni et al. · HemaSphere · 2023 · 38 citations · Full text

Life Sciences, Immunology, Oncology +17

Genomic landscape of multiple myeloma and its precursor conditions

Jean-Baptiste Alberge, Ankit K. Dutta, Andrea Poletti et al. · Nature Genetics · 2025 · 29 citations · Full text

Medicine, Genetics, Molecular Genetics +14